Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes.
macrovascular
microvascular
pre-diabetes
retinopathy
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
18
11
2019
revised:
22
03
2020
accepted:
28
03
2020
entrez:
26
4
2020
pubmed:
26
4
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes by glycemic status within 3 years before diagnosis. We identified 159 736 individuals with newly diagnosed type 2 diabetes from the UK Clinical Practice Research Datalink database in England between 2004 and 2017. We used logistic regression models to compare presence of microvascular (retinopathy and nephropathy) and macrovascular (acute coronary syndrome, cerebrovascular and peripheral arterial disease) disease at the time of type 2 diabetes diagnosis by prior glycemic status. Half of the study population (49.9%) had at least one vascular disease, over one-third (37.4%) had microvascular disease, and almost a quarter (23.5%) had a diagnosed macrovascular disease at the time of type 2 diabetes diagnosis.Compared with individuals with glycemic values within the normal range, those detected with pre-diabetes before the diagnosis had 76% and 14% increased odds of retinopathy and nephropathy (retinopathy: adjusted OR (AOR) 1.76, 95% CI 1.69 to 1.85; nephropathy: AOR 1.14, 95% CI 1.10 to 1.19), and 7% higher odds of the diagnosis of acute coronary syndrome (OR 1.07, 95% CI 1.03 to 1.12) in fully adjusted models at time of diabetes diagnosis. Microvascular and macrovascular diseases are detected in 37%-24% of people with newly diagnosed type 2 diabetes. Pre-diabetes before diagnosis of type 2 diabetes is associated with increased odds of microvascular disease and acute coronary syndrome. Detection of pre-diabetes might represent an opportunity for reducing the burden of microvascular and macrovascular disease through heightened attention to screening for vascular complications.
Identifiants
pubmed: 32332069
pii: 8/1/e001061
doi: 10.1136/bmjdrc-2019-001061
pmc: PMC7202749
pii:
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ann Fam Med. 2009 Nov-Dec;7(6):555-8
pubmed: 19901316
Diabetes Care. 2003 Sep;26(9):2604-8
pubmed: 12941726
BMJ. 2012 Jun 07;344:e3564
pubmed: 22677795
BMJ. 2003 May 24;326(7399):1130
pubmed: 12763987
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Diabetes Care. 2009 Jul;32(7):1327-34
pubmed: 19502545
Lancet Diabetes Endocrinol. 2018 May;6(5):392-403
pubmed: 29500121
Lancet Diabetes Endocrinol. 2017 Jan;5(1):34-42
pubmed: 27863979
Diabetologia. 2013 Jul;56(7):1489-93
pubmed: 23584433
BMJ. 2016 Nov 23;355:i5953
pubmed: 27881363
Exp Biol Med (Maywood). 2016 Jun;241(12):1323-31
pubmed: 27302176
Atherosclerosis. 2018 Nov;278:1-6
pubmed: 30227266
Med Clin North Am. 2011 Mar;95(2):309-25, vii
pubmed: 21281835
Diabetes Care. 2016 Aug;39(8):1472-7
pubmed: 27457639
Diabet Med. 2007 Feb;24(2):137-44
pubmed: 17257275
Diabetes Care. 2012 May;35(5):1050-2
pubmed: 22456865
Diabetes Care. 2019 Mar;42(3):416-426
pubmed: 30104301
Diabet Med. 2019 Mar;36(3):316-325
pubmed: 30466172
BMJ. 2012 Aug 30;345:e5567
pubmed: 22936794
Diabetes Care. 2015 Aug;38(8):1449-55
pubmed: 25986661
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
J Innov Health Inform. 2017 Oct 17;24(3):942
pubmed: 29121851
BMJ. 2014 Jul 15;349:g4485
pubmed: 25028385
Ann Fam Med. 2006 Sep-Oct;4(5):427-32
pubmed: 17003143
Diabetes. 2007 Aug;56(8):2054-61
pubmed: 17473220
J Epidemiol Community Health. 2019 Jan;73(1):11-18
pubmed: 30282645
Lancet Diabetes Endocrinol. 2018 May;6(5):354-356
pubmed: 29500120
Diabetes Care. 2014 Jun;37(6):1668-74
pubmed: 24705614
Clin Nephrol. 2007 May;67(5):293-7
pubmed: 17542338
Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461
pubmed: 31036503
Circulation. 2008 Mar 25;117(12):1610-9
pubmed: 18299505
Diabet Med. 2016 Dec;33(12):1615-1624
pubmed: 26997583
Diabetes Care. 2020 Jan;43(1):152-160
pubmed: 31719054
Endocrinol Metab Clin North Am. 2018 Mar;47(1):33-50
pubmed: 29407055
J Diabetes Investig. 2017 Sep;8(5):646-655
pubmed: 28267267
Lancet. 2009 Jun 27;373(9682):2215-21
pubmed: 19515410
Ann Intern Med. 2015 Sep 15;163(6):437-51
pubmed: 26167912
Diabetes Care. 2018 Apr;41(4):899-906
pubmed: 29453200
Sci Rep. 2020 Jan 27;10(1):1231
pubmed: 31988330
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
JAMA. 2014 Mar 26;311(12):1225-33
pubmed: 24668104
JAMA Neurol. 2020 May 4;:
pubmed: 32364569
Diabetologia. 2013 Jan;56(1):109-11
pubmed: 23052061
BMJ. 2017 Jan 4;356:i6538
pubmed: 28052845
Lancet Diabetes Endocrinol. 2017 Nov;5(11):848-849
pubmed: 28781065